MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration
- PMID: 29689563
- DOI: 10.1159/000489111
MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration
Retraction in
-
Retraction Statement.Cell Physiol Biochem. 2020;54(5):1097. doi: 10.33594/000000299. Cell Physiol Biochem. 2020. PMID: 33112094 No abstract available.
Abstract
Background/aims: Breast cancer (BC) starts as a local disease, but it can metastasize to the lymph nodes and distant organs. However, the metastatic process is still poorly understood. The mRNA microarray datasets GSE26910 and GSE33447 show that CXCL10 is up-regulated in BC, and the microRNA microarray dataset GSE38167 and a network meta-analysis of microRNA expression profile studies in human BC suggest that microRNA-34a (miR-34a) is down-regulated in BC. CXCL10 was predicted as a target of miR-34a by microRNA.org. In this study, we uncovered a CXCL10-independent mechanism by which miR-34a exerts its antimetastatic activity in BC.
Methods: To investigate the clinical significance of miR-34a in BC, we collected cancer tissues and paracancerous tissues from 258 patients with BC. In addition, a series of inhibitors, mimics, and siRNAs was introduced into MCF-7 and T47D cells to validate the regulatory mechanisms by which miR-34a regulates CXCL10. Next, to better understand the pivotal role of TLR signaling pathway inhibition in MCF-7 and T47D cells, we blocked the TLR signaling pathway using OxPAPC, an antagonist of TLR signaling.
Results: Among BC patients, miR-34a was down-regulated, CXCL10 was up-regulated, and the TLR signaling pathway was activated. Determination of luciferase activity revealed that CXCL10 was a target of miR-34a. Through gain- and loss-of-function studies, miR-34a was demonstrated to negatively regulate CXCL10; inhibit activation of the TLR signaling pathway; significantly suppress in vitro cell proliferation, migration, and invasion; and induce apoptosis.
Conclusion: Our findings suggest that functional loss or suppression of the tumor suppressor CXCL10 due to induction of miR-34a leads to inhibition of the TLR signaling pathway during breast tumorigenesis, providing a novel target for the molecular treatment of breast malignancies.
Keywords: Breast cancer; CXCL10; Invasion; MicroRNA-34a; Migration; TLR signaling pathway.
© 2018 The Author(s). Published by S. Karger AG, Basel.
Similar articles
-
In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.Oncotarget. 2017 Feb 28;8(9):15507-15519. doi: 10.18632/oncotarget.14662. Oncotarget. 2017. PMID: 28099945 Free PMC article.
-
Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.Med Sci Monit. 2019 Sep 23;25:7149-7157. doi: 10.12659/MSM.917562. Med Sci Monit. 2019. PMID: 31544897 Free PMC article.
-
Circ_0000514 promotes breast cancer progression by regulating the miR-296-5p/CXCL10 axis.J Biochem. 2022 Jan 7;170(6):753-761. doi: 10.1093/jb/mvab097. J Biochem. 2022. PMID: 34528678
-
Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.Curr Pharm Biotechnol. 2019;20(8):665-673. doi: 10.2174/1389201020666190617162042. Curr Pharm Biotechnol. 2019. PMID: 31244419 Review.
-
Overview of the miR-29 family members' function in breast cancer.Int J Biol Macromol. 2023 Mar 1;230:123280. doi: 10.1016/j.ijbiomac.2023.123280. Epub 2023 Jan 15. Int J Biol Macromol. 2023. PMID: 36652981 Review.
Cited by
-
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer.Noncoding RNA. 2020 Jul 13;6(3):29. doi: 10.3390/ncrna6030029. Noncoding RNA. 2020. PMID: 32668603 Free PMC article. Review.
-
Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application.Curr Neuropharmacol. 2020;18(2):153-166. doi: 10.2174/1570159X17666191010094849. Curr Neuropharmacol. 2020. PMID: 31660836 Free PMC article. Review.
-
Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.Breast Cancer (Dove Med Press). 2020 Dec 8;12:267-277. doi: 10.2147/BCTT.S284076. eCollection 2020. Breast Cancer (Dove Med Press). 2020. PMID: 33324095 Free PMC article.
-
Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells.Oncol Lett. 2020 Mar;19(3):2123-2132. doi: 10.3892/ol.2020.11327. Epub 2020 Jan 22. Oncol Lett. 2020. PMID: 32194710 Free PMC article.
-
TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.Int J Mol Sci. 2020 Apr 28;21(9):3114. doi: 10.3390/ijms21093114. Int J Mol Sci. 2020. PMID: 32354122 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical